Author:
Davidson Beverly L.,Breakefield Xandra O.
Publisher
Springer Science and Business Media LLC
Reference176 articles.
1. Bohn, M. A. Parkinson's disease: A neurodegenerative disease particularly amenable to gene therapy. Mol. Ther. 1, 494–496 (2000).
2. Sly, W. S. & Vogler, C. Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood–brain barrier. Proc. Natl Acad. Sci. USA 99, 5760–5762 (2002).
3. Kay, M. A., Glorioso, J. & Naldini, L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nature 7, 33–40 (2001).
4. Bartlett, J. S., Samulski, R. J. & McCown, T. J. Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum. Gene Ther. 9, 1181–1186 (1998). Showed the uptake of pre-labelled viral particles into specific cells in the brain, confirming the selective tropism of AAV2 for neurons.
5. Haberman, R. et al. Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity. Mol. Ther. 6, 495–500 (2002).
Cited by
277 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献